JC230 Submitted by ناشناس (تایید نشده) on 6 October 2021 Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and - or a sulphonylurea: A 52-week open-label, randomized phase III trial تاریخ ارائه 1397/11/27 تفسیر آماری
